Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (4): 583-586    DOI: 10.31083/j.ejgo.2020.04.3687
Original Research Previous articles | Next articles
Demodex folliculorum mite infestation in gynecological cancers: A case control study
Zeyneb Bakacak1, Mustafa Kaplanoğlu2, *(), Murat Bakacak3, Tuncay çelik4
1Private Practice of Obstetrics and Gynecology, Kahramanmaraş, Turkey
2Cukurova University School of Medicine, Department of Obstetric and Gynecology, Adana Turkey
3Kahramanmaras Sutcu Imam University School of Medicine, Department of Obstetric and Gynecology, Kahramanmaras, Turkey
4 Adiyaman University School of Medicine, Department of Parasitology, Adiyaman, Turkey
Download:  PDF(157KB)  ( 422 ) Full text   ( 11 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: To determine the frequency of Demodex (D.) folliculorum infestation in patients with gynecological cancer. Materials and Methods: This cross-sectional study was conducted between January 2015 and May 2015. Eighty-seven patients with gynecologic cancer and ninety control subjects were included and the patients characterics were recorded. Demodex was detected by standardized skin surface biopsy for skin lesions. Results: No statistically significant difference was found between the groups in terms of age, diabetes mellitus, body mass index (BMI), hypertension, and the use of radiotherapy and chemotherapy. D. folliculorum infestation was increased in the patient group (47.1%) when compared to the control group (8.9%) (p < 0.001). The frequency of D. folliculorum was higher in the cancer groups and particularly in ovarian cancer (58.7%). Conclusions: Patients with gynecological cancers are at risk for D. folliculorum mite infestation and this is explained by the immunosuppressed condition of the patients due to the cancer.
Key words:  Gynecological cancer      Demodex folliculorum     
Submitted:  19 February 2016      Accepted:  13 April 2016      Published:  15 August 2020     
*Corresponding Author(s):  MUSTAFA KAPLANOGLU     E-mail:  mustafakaplanoglu@hotmail.com

Cite this article: 

Zeyneb Bakacak, Mustafa Kaplanoğlu, Murat Bakacak, Tuncay çelik. Demodex folliculorum mite infestation in gynecological cancers: A case control study. European Journal of Gynaecological Oncology, 2020, 41(4): 583-586.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.04.3687     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I4/583

[1] X.F. Xu, Q. Li, A.Y. Dai, H.J. Zhou, J.X. Ling. Neoadjuvant chemotherapy followed by radical surgery for Stage IB2 cervical cancer in pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 489-491.
[2] M. Sakaguchi, T. Maebayashi, T. Aizawa, N. Ishibashi, T. Saito. High-dose-rate intracavitary brachytherapy for non-palpable and non-visible recurrent vaginal stump tumors after hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 54-59.
[3] D. Charatsi, M. Tolia, P.Vanakara, N. Tsoukalas, M. Nikolaou, D. Korfias, G. Nikolaou, A. Daponte, G. Kyrgias. Vaginal stenosis after radiation therapy for pelvic cancer: prevention and treatment options - a review of the current literature[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 185-189.
[4] S. Soeda, T. Watanabe, S. Nomura, M. Kojima, S. Furukawa, H. Endo, Z. Saze, T. Ozeki, H. Nishiyama, A. Kenjo, T. Takahashi, H. Yamada, K. Fujimori. Surgical management of recurrent gynecological cancer: Complete resection is the key to longer survival[J]. European Journal of Gynaecological Oncology, 2019, 40(1): 28-35.
[5] M. Kozaki, T. Ooyama, W. Kudaka, T. Nakamoto, A. Wakayama, Y. Aoki. Prevalence of pulmonary embolism in gynecological cancer: the experience of a single tertiary center in Okinawa, Japan[J]. European Journal of Gynaecological Oncology, 2018, 39(1): 44-48.
No Suggested Reading articles found!